We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Major Step Toward Precision Medicine for Malignant Brain Tumors

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)

brain scan
AGE: 18 years and older
GENDER: All
TYPE: Interventional Treatment Study
HEALTHY PARTICIPANTS: No
CONDITION: Glioblastoma mulitforme (GBM)
LOCATION: UH Seidman Cancer Center

Learn More About This Research Study

For more information, please contact Carmen Whatley, RN, the study coordinator at 855-948-3462 or complete the online form below.

Purpose of Study

The purpose of this study is to evaluate multiple investigational treatments for either newly diagnosed or recurrent glioblastoma to determine if any of these investigational treatments(s) improve how long patients live (overall survival) as compared to standard treatments. The study design allows multiple therapies and combinations of therapies to be screened simultaneously and over time.

Who Can Participate?

Patients 18 years or older who have been newly diagnosed with glioblastoma (GBM) or recurrent GBM may be eligible to participate in the study.

To learn more about this study, please fill out the form below to request more information.
Requestor’s information
XXX-XXX-XXXX
I'm not a robot

Study ID